National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Tuberculosis
 Understanding TB
  Overview
  What is TB?
   TB Definitions
   Detailed Explanation of TB
   Drug-Resistant TB Visual Tour
   Scientific Illustrations of Drug-Resistant TB
  TB in History
  Cause
  Transmission
  Symptoms
  Diagnosis
  Treatment
  Prevention
  TB and HIV
  Publications
 Research


Tuberculosis (TB)

TB Definitions

Tuberculosis (TB)

Tuberculosis, commonly known as TB, is an often severe and contagious airborne disease caused by a bacterial infection. TB typically affects the lungs but it also may affect any other organ of the body. It is usually treated with a regimen of drugs taken for six months to two years depending on the type of infection.

Multidrug-Resistant Tuberculosis (MDR TB)

MDR TB is a form of drug-resistant TB in which the TB bacteria can no longer be killed by at least the two best antibiotics, isoniazid (INH) and rifampin (RIF), commonly used to cure TB. As a result, this form of the disease is more difficult to treat than ordinary TB and requires up to two years of multidrug treatment.

Extensively Drug-Resistant Tuberculosis (XDR TB)

XDR TB is a less common form of multidrug-resistant TB in which the TB bacteria have changed enough to circumvent the two best antibiotics, isoniazid (INH) and rifampin (RIF), as well as most of the alternative drugs used against MDR TB. These second-line drugs include any fluoroquinolone, and at least one of the other three injectable anti-TB drugs: amikacin, kanamycin, or capreomycin. As a result, XDR TB needs up to two years of extensive drug treatment and is the most challenging to treat.

View Detailed Explanation of TB

 


View Drug-Resistant TB—A Visual Tour

Volunteer for Clinical Studies
Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.

See Also

Global Research, Africa

E-mail Icon E-mail this page
Print Icon Print this page
 


View Drug-Resistant TB—A Visual Tour

Volunteer for Clinical Studies
Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.

See Also

Global Research, Africa